Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization's Role as a Treatment Modality.
Journal: International journal of molecular sciences
Published: June 10, 2023
Reversal of diabetic retinopathy in two patients following the use of physiologic insulin Resensitization.
Journal: Journal of diabetes and its complications
Published: February 15, 2023
Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: A retrospective study and review of insulin secretion and action.
Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity
Published: January 05, 2023
Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology.
Journal: International journal of molecular sciences
Published: December 22, 2021
Resolution of Coronavirus Disease 2019 Infection and Pulmonary Pathology With Nebulized DAS181: A Pilot Study.
Journal: Critical care explorations
Published: November 02, 2020
Efficacy, Pharmacokinetics, and Safety Over 48 Weeks With Ibalizumab-Based Therapy in Treatment-Experienced Adults Infected With HIV-1: A Phase 2a Study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 13, 2020
DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 29, 2020
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
Journal: The New England journal of medicine
Published: August 16, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026